Literature DB >> 17245436

Lethal recessive myelin toxicity of prion protein lacking its central domain.

Frank Baumann1, Markus Tolnay, Christine Brabeck, Jens Pahnke, Ulrich Kloz, Hartmut H Niemann, Mathias Heikenwalder, Thomas Rülicke, Alexander Bürkle, Adriano Aguzzi.   

Abstract

PrP(C)-deficient mice expressing prion protein variants with large amino-proximal deletions (termed PrP(DeltaF)) suffer from neurodegeneration, which is rescued by full-length PrP(C). We now report that expression of PrP(DeltaCD), a PrP variant lacking 40 central residues (94-134), induces a rapidly progressive, lethal phenotype with extensive central and peripheral myelin degeneration. This phenotype was rescued dose-dependently by coexpression of full-length PrP(C) or PrP(C) lacking all octarepeats. Expression of a PrP(C) variant lacking eight residues (114-121) was innocuous in the presence or absence of full-length PrP(C), yet enhanced the toxicity of PrP(DeltaCD) and diminished that of PrP(DeltaF). Therefore, deletion of the entire central domain generates a strong recessive-negative mutant of PrP(C), whereas removal of residues 114-121 creates a partial agonist with context-dependent action. These findings suggest that myelin integrity is maintained by a constitutively active neurotrophic protein complex involving PrP(C), whose effector domain encompasses residues 94-134.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17245436      PMCID: PMC1783444          DOI: 10.1038/sj.emboj.7601510

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  36 in total

1.  Pronuclear microinjection of mouse zygotes.

Authors:  Thomas Rülicke
Journal:  Methods Mol Biol       Date:  2004

2.  Overexpression of PrPc triggers caspase 3 activation: potentiation by proteasome inhibitors and blockade by anti-PrP antibodies.

Authors:  E Paitel; C Alves da Costa; D Vilette; J Grassi; F Checler
Journal:  J Neurochem       Date:  2002-12       Impact factor: 5.372

3.  Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol.

Authors:  Jiyan Ma; Robert Wollmann; Susan Lindquist
Journal:  Science       Date:  2002-10-17       Impact factor: 47.728

4.  No superoxide dismutase activity of cellular prion protein in vivo.

Authors:  Gregor Hutter; Frank L Heppner; Adriano Aguzzi
Journal:  Biol Chem       Date:  2003-09       Impact factor: 3.915

Review 5.  The role of PrP in health and disease.

Authors:  E Flechsig; C Weissmann
Journal:  Curr Mol Med       Date:  2004-06       Impact factor: 2.222

6.  Primary cultured neurons devoid of cellular prion display lower responsiveness to staurosporine through the control of p53 at both transcriptional and post-transcriptional levels.

Authors:  Erwan Paitel; Claire Sunyach; Cristine Alves da Costa; Jean-Christophe Bourdon; Bruno Vincent; Frédéric Checler
Journal:  J Biol Chem       Date:  2003-10-21       Impact factor: 5.157

7.  Cross-linking cellular prion protein triggers neuronal apoptosis in vivo.

Authors:  Laura Solforosi; Jose R Criado; Dorian B McGavern; Sebastian Wirz; Manuel Sánchez-Alavez; Shuei Sugama; Lorraine A DeGiorgio; Bruce T Volpe; Erika Wiseman; Gil Abalos; Eliezer Masliah; Donald Gilden; Michael B Oldstone; Bruno Conti; R Anthony Williamson
Journal:  Science       Date:  2004-01-29       Impact factor: 47.728

Review 8.  Mammalian prion biology: one century of evolving concepts.

Authors:  Adriano Aguzzi; Magdalini Polymenidou
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

9.  Novel proteinaceous infectious particles cause scrapie.

Authors:  S B Prusiner
Journal:  Science       Date:  1982-04-09       Impact factor: 47.728

10.  Prion protein is a component of the multimolecular signaling complex involved in T cell activation.

Authors:  Vincenzo Mattei; Tina Garofalo; Roberta Misasi; Annapia Circella; Valeria Manganelli; Giuseppe Lucania; Antonio Pavan; Maurizio Sorice
Journal:  FEBS Lett       Date:  2004-02-27       Impact factor: 4.124

View more
  115 in total

Review 1.  Prion protein at the crossroads of physiology and disease.

Authors:  Emiliano Biasini; Jessie A Turnbaugh; Ursula Unterberger; David A Harris
Journal:  Trends Neurosci       Date:  2011-12-01       Impact factor: 13.837

Review 2.  Prion potency in stem cells biology.

Authors:  Marilene H Lopes; Tiago G Santos
Journal:  Prion       Date:  2012-04-01       Impact factor: 3.931

3.  Memory impairment in transgenic Alzheimer mice requires cellular prion protein.

Authors:  David A Gimbel; Haakon B Nygaard; Erin E Coffey; Erik C Gunther; Juha Laurén; Zachary A Gimbel; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

4.  A nine amino acid domain is essential for mutant prion protein toxicity.

Authors:  Laura Westergard; Jessie A Turnbaugh; David A Harris
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

Review 5.  Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.

Authors:  Julie A Moreno; Glenn C Telling
Journal:  Methods Mol Biol       Date:  2017

6.  De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis.

Authors:  Christina J Sigurdson; K Peter R Nilsson; Simone Hornemann; Mathias Heikenwalder; Giuseppe Manco; Petra Schwarz; David Ott; Thomas Rülicke; Pawel P Liberski; Christian Julius; Jeppe Falsig; Lothar Stitz; Kurt Wüthrich; Adriano Aguzzi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-10       Impact factor: 11.205

7.  Perturbation of T-cell development by insertional mutation of a PrP transgene.

Authors:  Mark Zabel; Christina Greenwood; Alana M Thackray; Bruce Pulford; Willem Rens; Raymond Bujdoso
Journal:  Immunology       Date:  2008-10-21       Impact factor: 7.397

8.  Dominant-negative effects of the N-terminal half of prion protein on neurotoxicity of prion protein-like protein/doppel in mice.

Authors:  Daisuke Yoshikawa; Naohiro Yamaguchi; Daisuke Ishibashi; Hitoki Yamanaka; Nobuhiko Okimura; Yoshitaka Yamaguchi; Tsuyoshi Mori; Hironori Miyata; Kazuto Shigematsu; Shigeru Katamine; Suehiro Sakaguchi
Journal:  J Biol Chem       Date:  2008-06-18       Impact factor: 5.157

9.  Context dependent neuroprotective properties of prion protein (PrP).

Authors:  Andrew D Steele; Zhipeng Zhou; Walker S Jackson; Chunni Zhu; Pavan Auluck; Michael A Moskowitz; Marie-Francoise Chesselet; Susan Lindquist
Journal:  Prion       Date:  2009-10-16       Impact factor: 3.931

Review 10.  Cellular prion protein mediates the toxicity of beta-amyloid oligomers: implications for Alzheimer disease.

Authors:  Haakon B Nygaard; Stephen M Strittmatter
Journal:  Arch Neurol       Date:  2009-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.